Verseau is the Macrophage Company Transforming Immunotherapy. Founded in 2017, Verseau Therapeutics is backed by investors that include 20/20 HealthCare Partners, 3sbio, Alexandria Venture Investments, Highlight Capital, and Yonghua Capital and is headquartered in Bedford.